Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Haloperidol versus placebo – 1 trial, 40 participants [15]

From: TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243]

Main outcomes Hal'dol Placebo RR (95% CI)
Not improved by 2 hours 2/29 4/11 0.19 (0.04–0.9)
Needing another injection Majority in both groups
Mental state: asleep – by 2 hours 1/29 0/11 -
Leaving the study early 0/29 0/11 -
Adverse effects: needing antiparkinsonian medication 6/29 0/11 -